Cardenas Jessica C
Division of Acute Care Surgery and Center for Translationssal Injury Research, Department of Surgery, McGovern School of Medicine, The University of Texas Health Science Center, Houston, Texas.
Shock. 2021 Nov 1;56(5):682-690. doi: 10.1097/SHK.0000000000001773.
Thrombin is the central coagulation enzyme that catalyzes the conversion of fibrinogen to form insoluble fibrin blood clots. In vivo, thrombin production results from the concerted effort of plasma enzymatic reactions with essential contributions from circulating and vessel wall cells. The relative amount of thrombin produced directly dictates the structure and stability of fibrin clots; therefore, sufficient thrombin generation is essential for normal hemostasis to occur. Examination of thrombin generation phenotypes among severely injury trauma patients reveals important relationships between the potential for generating thrombin and risks of bleeding and thrombotic complications. Thus, understanding determinants of thrombin generation following traumatic injury is of high clinical importance. This review will focus on patterns and mechanisms of thrombin generation in severely injured patients, the role of fluid resuscitation in modulating thrombin generation and implications for outcomes.
凝血酶是一种核心凝血酶,可催化纤维蛋白原转化为不溶性纤维蛋白血凝块。在体内,凝血酶的产生源于血浆酶促反应的协同作用,循环细胞和血管壁细胞发挥了重要作用。直接产生的凝血酶的相对量直接决定了纤维蛋白凝块的结构和稳定性;因此,产生足够的凝血酶对于正常止血至关重要。对严重创伤患者凝血酶生成表型的研究揭示了凝血酶生成潜力与出血和血栓形成并发症风险之间的重要关系。因此,了解创伤性损伤后凝血酶生成的决定因素具有很高的临床重要性。本综述将重点关注严重受伤患者凝血酶生成的模式和机制、液体复苏在调节凝血酶生成中的作用及其对预后的影响。